Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mechanisms of switching on p53: a role for covalent modification?

Oncogene volume 18, pages 7666–7675 (1999)Cite this article

Abstract

The p53 protein plays a pivotal role in activating and integrating adaptive cellular responses to a wide range of environmental stresses. Activation of p53 can occur by different molecular routes, depending on the nature of the activating signal. Central to the activation process, by whichever route, is the destabilization of the p53-MDM2 interaction. The molecular mechanisms which activate p53 involve elements of post-translational modification, protein stabilization and protein-protein interaction. Two central themes are emerging from recent work in this area. The first is that there are common events in the p53 activation process among different activating pathways. The second is that activation involves not just a single molecular event such as disruption of the p53-MDM2 interaction, but a series of sequential events the nature of which is governed by the type of activating stimulus. This review summarizes our current knowledge of the p53 activation process in response to two stimuli, DNA damage and activated oncogenes, and considers the contribution made by multisite phosphorylation in determining the nature of the p53 response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Abraham J, Spaner D and Benchimol S. . 1999 Oncogene 18: 1521–1527.

  • Adler V, Pincus MR, Minamoto T, Fuchs SY, Bluth MJ, Brandt-Rauf PW, Friedman FK, Robinson RC, Chen JM, Wang XW, Harris CC and Ronai Z. . 1997 Proc. Natl. Acad. Sci. USA 94: 1686–1691.

  • Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR. . 1998 J. Biol. Chem. 273: 1–4.

  • Anderson CW. . 1994 Semin. Cell Biol. 5: 427–436.

  • Anderson ME, Woelker B, Reed M, Wang P and Tegtmeyer P. . 1997 Mol. Cell. Biol. 17: 6255–6264.

  • Ashcroft M, Kubbutat MHG and Vousden KH. . 1999 Mol. Cell. Biol. 19: 1751–1758.

  • Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y. . 1998 Science 281: 1674–1677.

  • Barak Y, Juven T, Haffner R and Oren M. . 1993 EMBO J. 12: 461–468.

  • Baudier J, Delphin C, Grunwald D, Khochbin S and Lawrence JJ. . 1992 Proc. Natl. Acad. Sci. USA 89: 11627–11631.

  • Blattner C, Tobiasch E, Litfen M, Rahmsdorf HJ and Herrlich P. . 1999 Oncogene 18: 1723–1732.

  • Blaydes JP and Hupp TR. . 1998 Oncogene 17: 1045–1052.

  • Bottger A, Bottger V, Sparks A, Liu W-L, Howard SF and Lane DP. . 1997 Curr. Biol. 7: 860–869.

  • Bottger V, Bottger A, Garcia-Echeverria C, Ramos YFM, van der Eb AJ, Jochemsen AG and Lane DP. . 1999 Oncogene 18: 189–199.

  • Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD. . 1998 Science 281: 1677–1679.

  • Chernov MV, Ramana CV, Adler VA and Stark GR. . 1998 Proc. Natl. Acad. Sci. USA 95: 2284–2289.

  • Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL and Friend SH. . 1998 EMBO J. 17: 159–169.

  • de Stanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. . 1998 Genes Dev. 12: 2434–2442.

  • Delphin C and Baudier J. . 1994 J. Biol. Chem. 269: 29579–29587.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CJ, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Fried LM, Koumenis C, Peterson SR, Green SL, van Zijl P, Allalunis TJ, Chen DJ, Fishel R, Giaccia AJ, Brown JM and Kirchgessner CU. . 1996 Proc. Natl. Acad. Sci. USA 93: 13825–13830.

  • Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN and Ronai Z. . 1998a Genes Dev. 12: 2658–2663.

  • Fuchs SY, Adler V, Pincus MR and Ronai Z. . 1998b Proc. Natl. Acad. Sci. USA 95: 10541–10546.

  • Fukasawa K, Wiener F, Vande Woude GF and Mai S. . 1997 Oncogene 15: 1295–1302.

  • Giaccia AJ and Kastan MB. . 1998 Genes Dev. 12: 2973–2983.

  • Gu W and Roeder RG. . 1997 Cell 90: 595–606.

  • Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF and Danska JS. . 1996 Genes Dev. 10: 2038–2054.

  • Hao M, Lowy AM, Kapoor M, Deffie A, Liu G and Lozano G. . 1996 J. Biol. Chem. 271: 29380–29385.

  • Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296–299.

  • Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC. . 1996 Nucl. Acids Res. 24: 141–146.

  • Honda R and Yasuda H. . 1999 EMBO J. 18: 22–27.

  • Hu MC-T, Qui WR and Wang Y-P. . 1997 Oncogene 15: 2277–2287.

  • Hupp TR and Lane DP. . 1994 Cold Spring Harbor Symp. Quant. Biol. 59: 195–206.

  • Hupp TR, Meek DW, Midgley CA and Lane DP. . 1992 Cell 71: 875–886.

  • Jackson SP and Jeggo PA. . 1995 Trends Biochem. Sci. 20: 412–415.

  • Jongmans W, Artuso M, Vuillaume M, Bresil H, Jackson SP and Hall J. . 1996 Oncogene 13: 1133–1138.

  • Juven T, Barak Y, Zauberman A, George DL and Oren M. . 1993 Oncogene 8: 3411–3416.

  • Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel M and Sherr CJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 8292–8297.

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. . 1997 Cell 91: 649–659.

  • Kapoor M and Lozano G. . 1998 Proc. Natl. Acad. Sci. USA 95: 2834–2837.

  • Kastan MB, Zhan Q, El Deiry W, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. . 1992 Cell 71: 587–597.

  • Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP and Lavin MF. . 1998 Nature Genet. 20: 398–400.

  • Khanna KK and Lavin MF. . 1993 Oncogene 8: 3307–3312.

  • Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF and Meek DW. . 1997 Oncogene 15: 1727–1736.

  • Ko LJ, Shieh S-Y, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C and Pan Z-Q. . 1997 Mol. Cell. Biol. 17: 7220–7229.

  • Kubbutat MHG, Jones SN and Vousden KH. . 1997 Nature 387: 299–303.

  • Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R and Brady JN. . 1998 J. Biol. Chem. 273: 33048–33053.

  • Lees MS, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049.

  • Lees-Miller SP, Chen Y-R and Anderson CW. . 1990 Mol. Cell. Biol. 10: 6472–6481.

  • Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW. . 1998 Genes Dev. 12: 3008–3019.

  • Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD and Berger SL. . 1999 Mol. Cell. Biol. 19: 1202–1209.

  • Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. . 1992 Cell 70: 923–935.

  • Lu H, Fisher RP, Bailey P and Levine AJ. . 1997 Mol. Cell. Biol. 17: 5923–5934.

  • Lu H, Taya Y, Ikeda M and Levine AJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 6399–6402.

  • Mayo LD, Turchi JJ and Berberich SJ. . 1997 Cancer Res. 57: 5013–5016.

  • Meek DW. . 1997 Pathol. Biol. 45: 804–814.

  • Meek DW. . 1998 Cell. Signal. 10: 159–166.

  • Meek DW, Simon S, Kikkawa U and Eckhart W. . 1990 EMBO J. 9: 3253–3260.

  • Milne DM, Campbell DG, Caudwell FB and Meek DW. . 1994 J. Biol. Chem. 269: 9253–9260.

  • Milne DM, Campbell L, Campbell DG and Meek DW. . 1995 J. Biol. Chem. 270: 5511–5518.

  • Milne DM, McKendrick L, Jardine LJ, Deacon E, Lord JM and Meek DW. . 1996 Oncogene 13: 205–211.

  • Milne DM, Palmer RH, Campbell DG and Meek DW. . 1992 Oncogene 7: 1361–1369.

  • Mundt M, Hupp T, Fritsche M, Merkle C, Hansen S, Lane D and Groner B. . 1997 Oncogene 15: 237–244.

  • Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT and Jacks T. . 1996 Genes Dev. 10: 2055–2066.

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. . 1993 Nature 362: 857–860.

  • Palmero I, Pantoja C and Serrano M. . 1998 Nature 395: 125–126.

  • Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E and Brady JN. . 1998 J. Virol. 72: 6348–6355.

  • Pomerantz J, Schreiber-Agus N, Leigeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Condon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Prives C and Hall PA. . 1999 J. Path. 187: 112–126.

  • Quelle DE, Zindy F, Ashmunn RA and Sherr CJ. . 1995 Cell 83: 993–1000.

  • Rathmell WK, Kaufmann WK, Hurt JC, Byrd LL and Chu G. . 1997 Cancer Res. 57: 68–74.

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW and Appella E. . 1998 Genes Dev. 12: 2831–2841.

  • Sakaguchi K, Sakamoto M, Lewis MS, Anderson CW, Erikson JW, Appella E and Xie D. . 1997 Biochemistry 36: 10117–10124.

  • Serrano M, Hannon GJ and Beach D. . 1993 Nature 366: 704–707.

  • Shieh S-Y, Ikeda M, Taya Y and Prives C. . 1997 Cell 91: 325–334.

  • Shieh S-Y, Taya Y and Prives C. . 1999 EMBO J. 18: 1815–1823.

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E and Kastan MB. . 1997 Genes Dev. 11: 3471–3481.

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. . 1998 EMBO J. 17: 5001–5014.

  • Takenaka I, Morin F, Seizinger BR and Kley N. . 1995 J. Biol. Chem. 270: 5405–5411.

  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh S-Y, Taya Y, Prives C and Abraham RT. . 1999 Genes Dev. 13: 152–157.

  • Unger T, Juven-Gershon T, Moallem E, Berger M, Siononv RV, Lozano G, Oren M and Haupt Y. . 1999 EMBO J. 18: 1805–1814.

  • Wang Y and Prives C. . 1995 Nature 376: 88–91.

  • Waterman MJF, Stavridi ES, Waterman JLF and Halazonetis TD. . 1998 Nature Genet. 19: 175–178.

  • Watters D, Khanna KK, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhang N, Farrell A, Ramsay J, Gatti R and Lavin M. . 1997 Oncogene 14: 1911–1921.

  • Woo RA, McLure KG, Lees-Miller SP, Rancourt DE and Lee PWK. . 1998 Nature 394: 700–704.

  • Wright JA, Keegan KS, Heredeen DR, Bentley NJ, Carr AM, Hoekstra MF and Concannon P. . 1998 Proc. Natl. Acad. Sci. USA 95: 7445–7450.

  • Wu X, Bayle JH, Olson D and Levine AJ. . 1993 Genes Dev. 7: 1126–1132.

  • Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. . 1992 Cell 70: 937–948.

  • Zauberman A, Barak Y, Ragimov N, Levy N and Oren M. . 1993 EMBO J. 12: 2799–2808.

  • Zauberman A, Flusberg D, Haupt Y, Barak Y and Oren M. . 1995 Nucl. Acids Res. 23: 2584–2592.

  • Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. . 1998 Genes Dev. 12: 2424–2433.

Download references

Author information

Authors and Affiliations

  1. Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Scotland, Dundee, DD1 9SY, UK

    David W Meek

Authors
  1. David W Meek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meek, D. Mechanisms of switching on p53: a role for covalent modification?. Oncogene 18, 7666–7675 (1999). https://doi.org/10.1038/sj.onc.1202951

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202951

Keywords

This article is cited by

Search

Advanced search

Quick links